Tag: Vici
Stephen Black
Stephen Black speaks to Venous News about his career to date. Despite having, in his own words, done “terribly” in an interview for a...
Dedicated vs. non-dedicated: Researchers place venous stenting under the spotlight at...
Venous stenting was a hot topic on the agenda of the recent American Venous Forum (AVF) annual meeting (23–26 February, Orlando, USA). Catching the audience’s...
Boston Scientific and BD initiate venous stent recalls
Boston Scientific and BD have both initiated recalls of venous stents. According to a US Food and Drug Administration (FDA) medical device recall notice...
Mid-term follow-up data for venous stent confirms high patency in line...
Clinical outcomes with the Vici venous stent system (Boston Scientific) have been described as “very good”, according to a presentation of 24- and 36-month...
VIRTUS subanalysis identifies correlates to improved patient outcomes after venous stenting
Mahmood Razavi (Orange, USA) reported new data from a subanalysis of the VIRTUS trial, which set out to investigate the safety and efficacy of...
Veniti announces Boston Scientific distribution agreement for Vici venous stent
Boston Scientific will distribute Veniti’s Vici venous stent under a limited global distribution agreement. The terms of the agreement and specific regions and countries...